Cargando…

Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent

INTRODUCTION: Rheumatoid arthritis (RA) clinical guidelines do not provide strong recommendations for the choice of disease-modifying anti-rheumatic drugs (DMARD) in patients with an inadequate response to methotrexate (MTX), and only limited evidence is available on factors influencing rheumatologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Senbel, Eric, Durand, Frederick, Roux, Baptiste, Badaoui, Fatima-Zohra, Fautrel, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217392/ https://www.ncbi.nlm.nih.gov/pubmed/33939171 http://dx.doi.org/10.1007/s40744-021-00311-1

Ejemplares similares

Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees
por: Tsakas, James J., et al.
Publicado: (2022)

COVID-19 – rheumatic diseases and rheumatologists
por: Maślińska, Maria
Publicado: (2021)

Patients’ and rheumatologists’ preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain
por: Nolla, Joan M, et al.
Publicado: (2016)

Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
por: Morales-Torres, Jorge, et al.
Publicado: (2020)

Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
por: Lukas, Cédric, et al.
Publicado: (2019)

Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort
por: Kedra, Joanna, et al.
Publicado: (2022)

Patients’ and rheumatologists’ perceptions on preventive intervention in rheumatoid arthritis and axial spondyloarthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study
por: Kalkan, Almina, et al.
Publicado: (2014)

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
por: Bolge, Susan C, et al.
Publicado: (2016)

The Third Eye of the Rheumatologist: Applications of Musculoskeletal Ultrasound in Rheumatic Diseases
por: Chen, Hsin-Hua
Publicado: (2017)

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
por: Rivellese, Felice, et al.
Publicado: (2020)

Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea
por: Ha, So-Young, et al.
Publicado: (2021)

Gout, Rheumatism, and Rheumatoid Arthritis
Publicado: (1900)

Chronic Rheumatism and Rheumatoid Arthritis
por: Lindsay, J.
Publicado: (1908)

Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis
por: Glauser, Terry Ann, et al.
Publicado: (2014)

Influence of Continuing Medical Education on Rheumatologists’ Performance on National Quality Measures for Rheumatoid Arthritis
por: Sapir, Tamar, et al.
Publicado: (2015)

What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis
por: Díaz-Torné, Cesar, et al.
Publicado: (2020)

Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey
por: Pappas, Dimitrios A., et al.
Publicado: (2022)

Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
por: Fitzcharles, Mary-Ann, et al.
Publicado: (2014)

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders
por: Ablin, Jacob N., et al.
Publicado: (2016)

Promoting physical activity in patients with rheumatoid arthritis: rheumatologists’ and health professionals’ practice and educational needs
por: Hurkmans, Emalie J., et al.
Publicado: (2011)

Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists
por: Lesuis, N, et al.
Publicado: (2016)

Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
por: Jagpal, Aprajita, et al.
Publicado: (2019)

Rheumatologist’s Views on Oral Stage Dysphagia in adults with Rheumatoid Arthritis of the Temporomandibular Joint: An Irish Perspective
por: Órla, Gilheaney, et al.
Publicado: (2020)

A Treatise on Rheumatism and Rheumatoid Arthritis
Publicado: (1892)

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019)

Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis
por: Alpay-Kanitez, Nilüfer, et al.
Publicado: (2020)

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China
por: Chen, Miao, et al.
Publicado: (2021)

Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?
por: Di Bartolomeo, Salvatore, et al.
Publicado: (2020)

Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic‐Naive Rheumatoid Arthritis Patients
por: Kottak, Nicholas, et al.
Publicado: (2018)

Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis
por: Munro, Sarah, et al.
Publicado: (2018)

Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis
por: Navarro-Millán, Iris, et al.
Publicado: (2020)

The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist
por: De Cock, Diederik, et al.
Publicado: (2019)

Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat‐to‐Target Rates
por: Hsiao, Betty, et al.
Publicado: (2022)

Cataphoresis in the Treatment of Gout, Rheumatism, and Rheumatoid Arthritis
por: Begg, Charles
Publicado: (1902)

The Differential Diagnosis of Gout, Rheumatism, and Rheumatoid Arthritis
por: Luff, Arthur P.
Publicado: (1900)

Patient benefit–risk in arthritis—a rheumatologist’s perspective
por: Bijlsma, Johannes W. J.
Publicado: (2010)

Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19
por: Foti, Rosario, et al.
Publicado: (2020)

Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis
por: Wang, Hai-Long, et al.
Publicado: (2016)

Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohort
por: Ellegaard, Karen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g8bvh348j9ahekcrpifh6tspp5